Full name
PLUSPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Dispensing chemist in specialised stores
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.29.Z - Other retail sale of food in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
52.10.B - Warehousing and storage of other goods
78.10.Z - Activities of employment placement agencies
78.30.Z - Other human resources provision
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | 1 | -0,9 | -192,2 |
EBITDA | 3,5 | 2,7 | 0,9 | -67,6 |
Short time liabilities | 30,3 | 29,8 | 32,1 | 7,6 |
Equity capital | -17,5 | -15,5 | -17,5 | -12,8 |
Operating profit (EBIT) | 2,8 | 2 | 0,1 | -93,3 |
Assets | 13,9 | 15,9 | 16,5 | 3,8 |
Net profit (loss) | 1,6 | 2 | -2 | -200,5 |
Cash | 0,3 | 0,6 | 1,5 | 153,8 |
Net income from sale | 64,4 | 78,2 | 84,3 | 7,8 |
Liabilities and provisions for liabilities | 31,3 | 31,4 | 33,9 | 8,3 |
Working assets | 9,5 | 11,3 | 13,3 | 17,6 |
Depreciation | 0,7 | 0,7 | 0,7 | 5 |
% | % | % | p.p. | |
Profitability of capital | -9,3 | -12,8 | 11,4 | 24,2 |
Equity capital to total assets | -126,1 | -97,6 | -106,1 | -8,5 |
Gross profit margin | 2,4 | 1,2 | -1 | -2,2 |
EBITDA Margin | 5,4 | 3,5 | 1 | -2,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 171 | 139 | 139 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane